News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • 707 Cayman to enact 12-for-1 share consolidation effective July 14.
  • Post-consolidation, 707 Cayman will continue trading under ticker JEM on Nasdaq.
  • Rio Tinto reported stronger Q2 iron ore sales led by Pilbara operations.
  • Rio Tinto left its 2026 production guidance unchanged.
  • Rio's consolidated copper output slipped in Q2.
  • Rio narrowed its 2026 copper C1 cost range.
  • Rio said it is monitoring geopolitical risks that could affect supply chains.

Latest Articles

Genco Shipping & Trading Limited Board of Directors Provides Firm Commitments for Future Treatment of Shareholders Rights Agreement

Genco Shipping & Trading Limited Board of Directors Provides Firm Commitments for Future Treatment of Shareholders Rights Agreement

Genco Shipping & Trading Limited's Board of Directors reaffirms its commitment to protect shareholder interests by maintaining its Shareholder Rights Agreement to prevent a hostile takeover by Diana Shipping Inc. The Board encourages shareholders to vote in favor of continuing the Rights Agreement and reelect its current directors while rejecting D…

Ingredion Names Kenneth Escoe to Board of Directors

Ingredion Names Kenneth Escoe to Board of Directors

Ingredion Incorporated, a global ingredient solutions provider, has appointed Kenneth Escoe to its board of directors effective July 1. Escoe brings extensive leadership experience across capital-intensive businesses, focusing on operations, commercial strategy, and M&A, which is expected to support Ingredion's long-term growth.

IMDX GraftAssure Assay Sets New Standard in Screening Kidney Transplant Patients Per American Journal of Transplantation

IMDX GraftAssure Assay Sets New Standard in Screening Kidney Transplant Patients Per American Journal of Transplantation

Insight Molecular Diagnostics announced publication in the American Journal of Transplantation demonstrating the superior diagnostic performance of its GraftAssure Combination Model (CM)-score assay for detecting kidney transplant rejection. The CM-score, integrating relative and absolute donor-derived cell-free DNA measurements, shows increased po…

Seneca Foods Reports Sales and Earnings for the Quarter and Twelve Months Ended March 31, 2026

Seneca Foods Reports Sales and Earnings for the Quarter and Twelve Months Ended March 31, 2026

Seneca Foods Corporation reported increased net sales and improved gross margins for the fiscal year ended March 31, 2026, achieving record full-year FIFO diluted EPS of $14.15. The company also completed the acquisition of the U.S. Green Giant Frozen business, expanding its frozen product segment and market footprint. Quarterly results also showed…

Eos Energy Announces Record Date for Rights Offering

Eos Energy Announces Record Date for Rights Offering

Eos Energy Enterprises, a US-based innovator in zinc-based long-duration energy storage, announced the record date for a rights offering aimed at raising funds to support its capital contribution to the Frontier Power USA joint venture. Eligible holders of common stock and warrants will receive subscription rights to purchase units at a discount, i…

Helen Suzanne L Sells $697,152 in Mohawk Industries Stock

Helen Suzanne L Sells $697,152 in Mohawk Industries Stock

Helen Suzanne L, potentially acting as part of a broader group, liquidated a portion of her Mohawk Industries Inc. (NYSE: MHK) holdings on June 9, 2026. The transaction, executed indirectly through PASTrust fbo Suzanne Helen, totaled $697,152 across multiple market orders. Despite the insider selling, recent financial data shows Mohawk Industries e…

Boxlight CTO Shaun Marklew Sells $86 in Shares Ahead of Sharp Decline

Boxlight CTO Shaun Marklew Sells $86 in Shares Ahead of Sharp Decline

Shaun Marklew, Chief Technology Officer at Boxlight Corp (NASDAQ: BOXL), executed a small-scale sale of company stock on November 25, 2025, to satisfy tax withholding requirements tied to the vesting of restricted stock units. The transaction involved the sale of 17 shares at $5.10 per share, resulting in $86 in proceeds. Following this transaction…

Mohawk Industries Announces CEO Succession Plan

Mohawk Industries Announces CEO Succession Plan

Mohawk Industries announced that Paul F. De Cock will become CEO on September 30, 2026, succeeding Jeff Lorberbaum, who is retiring after leading the company for 25 years and will remain Chairman. De Cock brings extensive industry experience and has been instrumental in expanding Mohawk's global operations and product portfolio. The leadership tran…

Elutia to Present at Planet MicroCap Showcase 2026 on June 17th

Elutia to Present at Planet MicroCap Showcase 2026 on June 17th

Elutia Inc. announced that its CEO and CSO will present at the Planet MicroCap Showcase 2026, focusing on their drug-eluting biomatrix technology designed to mitigate post-surgical infection in implant-based breast reconstruction following mastectomy. The company highlights the potential to improve patient outcomes by reducing complications and rev…

Treace to Present at the Sidoti Small Cap Conference

Treace to Present at the Sidoti Small Cap Conference

Treace Medical Concepts, Inc., a Nasdaq-listed medical device company specializing in innovative surgical solutions for bunions and midfoot deformities, announced it will present at the Sidoti Small Cap Conference on June 18, 2026. The company is known for its patented Lapiplasty 3D Bunion Correction System and other surgical technologies designed …

Parabilis Medicines Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Parabilis Medicines Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Parabilis Medicines, a clinical-stage biopharmaceutical company developing novel medicines targeting historically undruggable proteins, closed its upsized initial public offering on Nasdaq under ticker PBLS at $20 per share. The IPO raised gross proceeds of $770.5 million, including full exercise of underwriters' over-allotment option. Additionally…

Kyntra Bio Presents New Roxadustat Data on Improvements in Transfusion Independence Regardless of Ring Sideroblast Status in Patients with Anemia due to Lower-Risk Myelodysplastic Syndromes

Kyntra Bio Presents New Roxadustat Data on Improvements in Transfusion Independence Regardless of Ring Sideroblast Status in Patients with Anemia due to Lower-Risk Myelodysplastic Syndromes

Kyntra Bio announced new data from the Phase 3 MATTERHORN trial showing the drug roxadustat significantly improves transfusion independence in patients with anemia due to lower-risk myelodysplastic syndromes (LR-MDS), regardless of ring sideroblast (RS) status. The company is finalizing the protocol for a pivotal Phase 3 trial based on FDA feedback…

CTW to Participate and Present at Planet MicroCap Las Vegas 2026

CTW to Participate and Present at Planet MicroCap Las Vegas 2026

CTW, a leading game platform company specializing in anime IP-based free-to-play web games, announced that CFO Patrick Liu will participate and present at the Planet MicroCap Las Vegas 2026 investment conference from June 16-18. The presentation and one-on-one meetings aim to engage investors and showcase CTW's business and growth strategies.

Raise Equity Now: Agentic AI & Asset Exposure Make Alphabet a Buy

Raise Equity Now: Agentic AI & Asset Exposure Make Alphabet a Buy

Alphabet is uniquely positioned to monetize the next wave of agentic AI while providing diversified upside through stakes in SpaceX and Anthropic. Fundamentals remain solid (market cap ~$4.34T, EPS $13.14, FCF $64.4B), valuation is reasonable for a compounder, and the current technical pullback offers a tactical entry. Actionable trade plan include…

Nanox to Report First Quarter 2026 Financial Results on June 25, 2026

Nanox to Report First Quarter 2026 Financial Results on June 25, 2026

Nanox Imaging Ltd announces it will release its first quarter 2026 financial results on June 25, 2026, followed by a conference call hosted by CEO Erez Meltzer and CFO Ran Daniel. The company provides an update on its integrated medical imaging platform aimed at expanding preventive healthcare through affordable imaging technology, AI analytics, cl…

5-Year Phase 2 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH in Adults with Hypoparathyroidism

5-Year Phase 2 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH in Adults with Hypoparathyroidism

Ascendis Pharma announced positive five-year Phase 2 data from the PaTH Forward Trial demonstrating that TransCon PTH (palopegteriparatide) provides sustained multi-organ benefits, normalizes calcium levels, improves kidney function and quality of life, and allows independence from conventional therapies in adults with hypoparathyroidism. High pati…